GlaxoSmithKline
This article was originally published in The Gray Sheet
Executive Summary
Safety Tip-Lok syringes with SafetyGlide needles, prefilled with pediatric doses of Havrix vaccine for hepatitis A and the hepatitis B vaccine Engerix-B, gain FDA approval, announced June 18. BD supplies the devices to drug maker GSK. The delivery system complies with the Occupational Safety and Health Administration's revised bloodborne pathogens standard to prevent needle-sticks, which went into effect April 18 ("The Gray Sheet" April 23, 2001, p. 13)...
You may also be interested in...
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.